↓ Skip to main content

Human Rights Responsibilities of Pharmaceutical Companies in Relation to Access to Medicines

Overview of attention for article published in The Journal of Law, Medicine & Ethics, January 2021
Altmetric Badge

Mentioned by

news
1 news outlet
blogs
1 blog
policy
1 policy source
twitter
2 X users

Citations

dimensions_citation
39 Dimensions

Readers on

mendeley
83 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Human Rights Responsibilities of Pharmaceutical Companies in Relation to Access to Medicines
Published in
The Journal of Law, Medicine & Ethics, January 2021
DOI 10.1111/j.1748-720x.2012.00660.x
Pubmed ID
Authors

Joo‐Young Lee, Paul Hunt

Abstract

Although access to medicines is a vital feature of the right to the highest attainable standard of health ("right to health"), almost two billion people lack access to essential medicines, leading to immense avoidable suffering. While the human rights responsibility to provide access to medicines lies mainly with States, pharmaceutical companies also have human rights responsibilities in relation to access to medicines. This article provides an introduction to these responsibilities. It briefly outlines the new UN Guiding Principles on Business and Human Rights and places the human rights responsibilities of pharmaceutical companies in this context. The authors draw from the work of the first UN Special Rapporteur on the right to the highest attainable standard of health, in particular the Human Rights Guidelines for Pharmaceutical Companies in Relation to Access to Medicines that he presented to the UN General Assembly in 2008, and his UN report on GlaxoSmithKline (GSK). While the Guiding Principles on Business and Human Rights are general human rights standards applicable to all business entities, the Human Rights Guidelines for Pharmaceutical Companies consider the specific human rights responsibilities of one sector (pharmaceutical companies) in relation to one area of activity (access to medicines). The article signals the human rights responsibilities of all pharmaceutical companies, with particular attention to patent-holding pharmaceutical companies. Adopting a right-to-health "lens," the article discusses GSK and accountability. The authors argue that human rights should shape pharmaceutical companies' policies, and provide standards in relation to which pharmaceutical companies could, and should, be held accountable. They conclude that it is now crucial to devise independent, accessible, transparent, and effective mechanisms to monitor pharmaceutical companies and hold them publicly accountable for their human rights responsibilities.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 83 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
United States 1 1%
Unknown 81 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 21 25%
Student > Ph. D. Student 12 14%
Student > Postgraduate 10 12%
Student > Bachelor 9 11%
Student > Doctoral Student 5 6%
Other 10 12%
Unknown 16 19%
Readers by discipline Count As %
Social Sciences 20 24%
Business, Management and Accounting 15 18%
Medicine and Dentistry 12 14%
Pharmacology, Toxicology and Pharmaceutical Science 3 4%
Arts and Humanities 3 4%
Other 11 13%
Unknown 19 23%